IN2013MU02986A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU02986A IN2013MU02986A IN2986MU2013A IN2013MU02986A IN 2013MU02986 A IN2013MU02986 A IN 2013MU02986A IN 2986MU2013 A IN2986MU2013 A IN 2986MU2013A IN 2013MU02986 A IN2013MU02986 A IN 2013MU02986A
- Authority
- IN
- India
- Prior art keywords
- agents
- group
- sodium
- gum
- sterculiafoetida
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The present invention provides an orally administrable gastro retentive dosage form comprising at least one pharmaceutically active ingredient; a combination of Sterculiafoetida gum and xanthan gum as polymer in a ratio of 0.5:1 to 3:l;at least one gas generating agent selected from the group consisting of sodium carbonate, sodium bicarbonate, sodium metabisulfite, calcium carbonate and mixtures thereof; and at least one excipient selected from the group consisting of binders, diluents, disintegrants, lubricating agents, -wetting agents, polymers, surfactants, sweeteners, flavours, pH adjusting agents, glidents, coating agents, plasticizers and colorants.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2986MU2013 IN2013MU02986A (en) | 2013-09-13 | 2013-09-13 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2986MU2013 IN2013MU02986A (en) | 2013-09-13 | 2013-09-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MU02986A true IN2013MU02986A (en) | 2015-10-09 |
Family
ID=54397044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2986MU2013 IN2013MU02986A (en) | 2013-09-13 | 2013-09-13 |
Country Status (1)
Country | Link |
---|---|
IN (1) | IN2013MU02986A (en) |
-
2013
- 2013-09-13 IN IN2986MU2013 patent/IN2013MU02986A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ735575A (en) | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use | |
EA201690962A1 (en) | COMPOSITIONS | |
PH12015501993B1 (en) | Pyrazole-amide compound and medicinal uses therefor | |
MX2016006053A (en) | Selective pyy compounds and uses thereof. | |
TN2011000172A1 (en) | Therapeutic antiviral peptides | |
PT2310356E (en) | Adamantyl diamide derivatives and uses of same | |
MY183312A (en) | Pharmaceutical formulation | |
MY187718A (en) | Pharmaceutical formulations | |
MX343689B (en) | Darunavir combination formulations. | |
JOP20190233A1 (en) | Benzoazepine analogs as inhibiting agents for bruton's tyrosine kinase | |
TN2015000135A1 (en) | Modified release formulations for oprozomib | |
MX341976B (en) | Darunavir formulations. | |
MD3482754T2 (en) | Pharmaceutical compositions and uses directed to lysosomal storage disorders | |
MY174005A (en) | Swallowable n-acetylcysteine tablets | |
EA201791009A1 (en) | COMPOSITIONS CONTAINING CYCLOSPORIN | |
EA202090542A1 (en) | HIGHLY CONCENTRATED MEDICINAL FORMS OF Pridopidine | |
EA201490166A1 (en) | Fluorinated arylalkyl-aminocarboxamide derivatives | |
JO3192B1 (en) | Benzothiazolone compound | |
NZ701103A (en) | Solid state forms of n-((s)-2,3-dihydroxy-propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide | |
BR112017019364A2 (en) | solid dispersions | |
IN2013MU02986A (en) | ||
MX2020007326A (en) | Dosing regimen of siponimod. | |
IN2013MU02985A (en) | ||
TN2015000156A1 (en) | Dispersible tablet | |
EA201500368A1 (en) | PHARMACEUTICAL COMPOSITION OF 1-ADAMANTYLETHYLOXY-3-MORFOLIN-2-PROPANOL OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR TREATING CARDIOVASCULAR PATHOLOGY |